Addition of Flucytosine to Fluconazole for the Treatment of Cryptococcal Meningitis in Africa: A Multicountry Cost-effectiveness Analysis

BACKGROUND: Mortality from cryptococcal meningitis remains very high in Africa. In the Advancing Cryptococcal Meningitis Treatment for Africa (ACTA) trial, 2 weeks of fluconazole (FLU) plus flucytosine (5FC) was as effective and less costly than 2 weeks of amphotericin-based regimens. However, many...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Clin Infect Dis
Main Authors: Shiri, Tinevimbo, Loyse, Angela, Mwenge, Lawrence, Chen, Tao, Lakhi, Shabir, Chanda, Duncan, Mwaba, Peter, Molloy, Síle F, Heyderman, Robert S, Kanyama, Cecilia, Hosseinipour, Mina C, Kouanfack, Charles, Temfack, Elvis, Mfinanga, Sayoki, Kivuyo, Sokoine, Chan, Adrienne K, Jarvis, Joseph N, Lortholary, Olivier, Jaffar, Shabbar, Niessen, Louis W, Harrison, Thomas S
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2020
Teme:
Articles and Commentaries
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6912152/
https://ncbi.nlm.nih.gov/pubmed/30816418
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciz163
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki